Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine analysts that are presently covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have issued a report on the […]
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have been assigned an average recommendation of “Buy” from the nine brokerages that are covering the stock, Marketbeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have issued ratings on the […]
Syndax Pharmaceuticals, Inc (NASDAQ:SNDX) Receives $36 00 Average PT from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Syndax Pharmaceuticals, Inc (NASDAQ:SNDX) Receives $36 00 Consensus Target Price from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Axiom Investors LLC DE acquired a new position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 28,195 shares of the company’s stock, valued at approximately $595,000. A number of other hedge funds […]